The Vital Role of Pharmacists in Healthcare
Pharmacists are more than just dispensers of medicine—they are essential healthcare professionals who bridge the gap between doctors and patients. With deep knowledge of drugs, their interactions, side effects, and proper usage, pharmacists ensure that medications are used safely and effectively.

Key Responsibilities of a Pharmacist:
Dispensing Medications: Accurately filling prescriptions and ensuring correct dosage.

Patient Counseling: Educating patients on how to take their medications and what to expect.

Monitoring Drug Interactions: Identifying potential harmful interactions between medications.

Promoting Public Health: Administering vaccines, supporting smoking cessation, and providing guidance on healthy living.

Collaborating with Healthcare Teams: Working closely with doctors and nurses to optimize patient care.

Why Pharmacists Matter:
Pharmacists play a critical role in reducing medication errors, improving treatment outcomes, and supporting chronic disease management. In rural and underserved areas, they are often the most accessible healthcare professionals.

🩺 Pharmacists are trusted advisors, advocates for patient health, and a cornerstone of our healthcare system. The next time you visit a pharmacy, remember—the person behind the counter could be a lifesaver.

DiponEd Research International Pvt Ltd-CRO supporting R&D development/Proof of concept formulations and analysis like solutions, suspensions, emulsions, cream, gel etc. in Bangalore R&D lab (NCEs, Conventional drugs, Herbals, Nutraceuticals etc.).

Contact us with your project requirements to Shruti@diponed.com & 9309893460

Higher tariffs imposed by the U.S. on certain pharmaceutical imports from India are unlikely to impact the country’s competitive edge in the American market, according to industry experts. India remains a dominant player in the U.S. pharmaceutical sector, supplying around 40% of generic drugs. Factors such as cost-efficient manufacturing, a skilled workforce, and regulatory compliance continue to support India’s strong market presence.

While the Biden administration has increased tariffs on some Chinese pharmaceutical ingredients, India is seen as a reliable alternative for drug production. The Indian pharmaceutical industry has also been expanding its manufacturing capabilities, reducing dependence on Chinese raw materials. This shift enhances supply chain resilience and ensures steady exports to the U.S.

Industry leaders believe that India’s ability to produce affordable, high-quality medicines will help it withstand tariff changes. Additionally, ongoing investments in research and development (R&D), innovation, and adherence to U.S. FDA standards reinforce India’s position as a preferred supplier.

Despite potential short-term cost pressures, Indian pharmaceutical firms are expected to remain competitive by leveraging economies of scale and focusing on high-value drug formulations. The long-term outlook remains positive, driven by global demand for affordable medicines and strong bilateral trade relations.


#IndiaPharma #USPharmaMarket #GenericDrugs #PharmaExports #TradeRelations #HealthcareIndustry #MedTech #Tariffs #PharmaManufacturing #SupplyChain #AffordableMedicine #PharmaInnovation #DrugSupply #FDACertified #HealthTech #GlobalPharma #PharmaceuticalIndustry #dseidehealthcarenetwork

Source: Financial Express

DSEIDE Entered the Pharma Industry!

After successful collaborations with Hospex India 2024 and the National Association of Geriatric Society of India at GSICON 2024 – the 37th National Annual Conference of Geriatric Society of India – we proudly achieved a major milestone:

DSEIDE expanded beyond healthcare into the pharma industry!

We were honored to partner with PharmaTech Expo and LabTech Expo 2025, where we provided an exclusive community space within the DSEIDE Healthcare Network. Exhibitors, partners, delegates, and speakers stayed better connected before, during, and after the grand 18th edition of this comprehensive Pharma, Lab, Life Science, and Biotech Expo.

Highlights of the Event:
200+ Exhibitors
6,000+ Visitors
International Pavilion
Conferences
Buyer-Seller Meet
Concurrent events on Life Sciences, Biotech, CRO, and more!

We took immense pride in supporting this prestigious event as a Digital Community Partner, alongside industry leaders like:

Pharma Pro & Pack Expo
Karnataka Drugs and Pharmaceuticals Manufacturers Association
FOPE (Federation of Pharma Entrepreneurs)
Indo-Arab Chamber of Commerce & Industries
BCIC (Bangalore Chamber of Industry and Commerce)
The Council of EU Chambers of Commerce in India
DMMA (Drugs Manufacturers' Association)
📅 Event Dates: January 8–10, 2025
📍 Venue: Bengaluru International Exhibition Centre (BIEC)

Together, we fostered opportunities for innovation, collaboration, and growth within the pharma and biotech industries.

Stay tuned for more updates as DSEIDE continues partnering with leading organizations to drive impactful change!

Dseide Entering Pharma Industry Now !

After successful collaborations with Hospex India 2024 and the National Association of Geriatric Society of India GSICON2024 - 37th National Annual Conference of Geriatric Society of India, and, we're thrilled to announce a major milestone:

Dseide is expanding beyond healthcare into the pharma industry!

We are proud to partner with @PharmaTech Expo and LabTec and given exclusive community space inside Dseide Healthcare Network Exhibitors , Partners, Delegates ,Speakers can stay connected stronger before , during and post the expo , for the grand 18th edition of their spectrum of Pharma, Lab, Life Science, and Biotech Expo.

This prestigious event will feature:
200+ Exhibitors
6,000+ Visitors
International Pavilion
Conferences
Buyer-Seller Meet
Concurrent events on Life Sciences, Biotech, CRO, and more!

Its our pride to support this event as Digital Community Partner along with Industry Leaders like

Pharma Pro & Pack Expo
Karnataka Drugs and Pharmaceuticals Manufacturers Association
FOPE (Federation of Pharma Entrepreneurs)
Indo-Arab Chamber of Commerce & Industries
BCIC (Bangalore Chamber of Industry and Commerce)
The Council of EU Chambers of Commerce in India
DMMA (Drugs Manufacturers' Association)

📅 Mark your calendar for January 8-10, 2025 at the Bengaluru International Exhibition Centre (BIEC).

Together, we aim to create opportunities for innovation, collaboration, and growth within the pharma and biotech industries.

Stay tuned for more exciting updates as Dseide partners with leading organizations to drive impactful change.

Nikhila C R Bharath M Ishika Singh Prerana M Nayaz Ahmed Mohammed Saqlain JAIN Launchpad Praveen D Jadhav

#Dseide #PharmaTechExpo #LifeSciences #PharmaIndustry #Biotech #HealthcareInnovation #BusinessGrowth #Collaboration #pharmainnovation #pharmatech #healthcareinnovation #healthtech

Excessive Bleeding After Dental Procedure
A 57-year-old man presents to the emergency department due to excessive bleeding following a dental cleaning procedure. The patient's medical background includes the following:

No prior history of uncontrolled bleeding, easy bruising, or any bleeding disorders.
Recent fever 4-5 days ago but no other constitutional symptoms like weight loss or night sweats.
No symptoms of shortness of breath, chest pain, palpitations, dizziness, or gastrointestinal bleeding (such as vomiting, abdominal pain, hematuria, constipation, melena, hematochezia, or hemoptysis).
No signs of systemic disease, such as oral ulcers, joint pain or stiffness, rashes, alopecia, or dryness of eyes or mouth.
Medical and Surgical History:
No chronic illnesses or regular medication use.
Surgical history includes hernia repair 6 years ago.
No use of tobacco, illicit drugs, or alcohol.
Family History:
Unremarkable, with no known bleeding disorders.
Diagnostic Considerations:
Given the patient's presentation of excessive bleeding after a dental procedure, several potential causes need to be considered, including:

Coagulation Disorders: Although the patient does not report a history of bleeding disorders, acquired conditions (e.g., vitamin K deficiency, liver dysfunction, or medication-induced coagulopathy) must be considered.
Infection-Related Bleeding Tendencies: Given the recent history of fever, it is possible that an infection or sepsis is affecting the coagulation cascade.
Thrombocytopenia: Causes may include recent infection, immune thrombocytopenic purpura (ITP), or other hematologic disorders.
Vascular Abnormalities or Trauma: Minor trauma from the dental procedure may have led to excessive bleeding if there is an underlying vascular issue.
Medications or Supplements Not Disclosed: Though the patient denies medication use, potential undisclosed use of antiplatelets, anticoagulants, or supplements such as omega-3 fatty acids or herbal supplements that affect coagulation should be explored.
Systemic Diseases: Autoimmune diseases, such as lupus or other connective tissue diseases, can cause bleeding tendencies, though the patient does not present with symptoms like rashes, oral ulcers, or joint pain.
Recommended Diagnostic Workup:
To investigate the underlying cause of excessive bleeding, the following steps should be taken:

Complete Blood Count (CBC): To check for thrombocytopenia or signs of anemia.
Coagulation Studies: Including Prothrombin Time (PT), Partial Thromboplastin Time (PTT), and International Normalized Ratio (INR) to assess clotting function.
Liver Function Tests: To rule out hepatic causes of coagulopathy.
Renal Function Tests: To rule out uremia, which can also affect platelet function.
Infectious Workup: Blood cultures and inflammatory markers (e.g., CRP, ESR) if infection is suspected.
Review of Recent Medications or Supplements: To confirm there are no undisclosed medications or supplements that could contribute to bleeding risk.

sources: Medscape